Movac - Growing great businesses

Growing great businesses

Movac is an investment manager that backs exceptional people with world-beating ideas - ideas that have the potential for rapid and large-scale growth. The philosophy of the Movac Investor Group is to back high growth potential businesses that will provide the foundations for the next wave of prosperity for the New Zealand economy. Movac has a track record of investment success, most notably in Trademe.

Our typical investment ranges from $100k to $1m. We will look at larger deals under syndication with other investors.

Active ventures

	Crema Capital Finance \| Hedge fund
	eBus Internet \| Media content management
	Flossie Media Group Internet \| On-line media channel for women
	Givealittle Internet \| On-line giving
	InspireGroup Information Technology \| eLearning Solutions
	Kaynemaile Platform technology \| Seamless Mesh
	Mesynthes BioTech \| Tissue scaffold
	MigCo BioTech \| Migraine treatment
	PowerByProxi Platform technology \| Unplugged power
	ReelClever Internet \| Media

Blog RSS

Mesynthes Obtains U.S. FDA 510(k) Clearance for Endoform Dermal Template™
WELLINGTON, NZ (February 2, 2010): Mesynthes, a privately held regenerative medicine company, today announced that the U. S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company's Endoform Dermal TemplateTM.